429 related articles for article (PubMed ID: 28325685)
41. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
[TBL] [Abstract][Full Text] [Related]
42. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
43. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
44. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
[TBL] [Abstract][Full Text] [Related]
45. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
46. Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient.
Dang J; Li Y; Yan J; Wu J; Cai K; Yin L; Zhou Z
Adv Healthc Mater; 2024 Jun; 13(15):e2304130. PubMed ID: 38427696
[TBL] [Abstract][Full Text] [Related]
47. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
[TBL] [Abstract][Full Text] [Related]
48. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
Wong RCH; Ng DKP; Fong WP; Lo PC
Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
[TBL] [Abstract][Full Text] [Related]
49. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
50. Formation of enzymatic/redox-switching nanogates on mesoporous silica nanoparticles for anticancer drug delivery.
Luo W; Xu X; Zhou B; He P; Li Y; Liu C
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():855-861. PubMed ID: 30948123
[TBL] [Abstract][Full Text] [Related]
51. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
[TBL] [Abstract][Full Text] [Related]
52. ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source.
Yue C; Yang Y; Zhang C; Alfranca G; Cheng S; Ma L; Liu Y; Zhi X; Ni J; Jiang W; Song J; de la Fuente JM; Cui D
Theranostics; 2016; 6(13):2352-2366. PubMed ID: 27877240
[TBL] [Abstract][Full Text] [Related]
53. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
54. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy.
Uthaman S; Pillarisetti S; Mathew AP; Kim Y; Bae WK; Huh KM; Park IK
Biomaterials; 2020 Feb; 232():119702. PubMed ID: 31896514
[TBL] [Abstract][Full Text] [Related]
55. Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery.
Xu L; Zhao M; Gao W; Yang Y; Zhang J; Pu Y; He B
Colloids Surf B Biointerfaces; 2019 Sep; 181():252-260. PubMed ID: 31153020
[TBL] [Abstract][Full Text] [Related]
56. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
57. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
58. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
Chen C; Sun W; Wang X; Wang Y; Wang P
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
[TBL] [Abstract][Full Text] [Related]
59. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
60. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]